Neoprospecta

Florianopolis, Brazil Founded: 2010 • Age: 16 yrs
Microbiome analysis and monitoring via NGS and bioinformatics are offered.

About Neoprospecta

Neoprospecta is a Healthcare company based in Florianopolis (Brazil) founded in 2010. Microbiome analysis and monitoring via NGS and bioinformatics are offered. Neoprospecta has raised $1.78 million across 1 funding round from investors including CVentures. Neoprospecta offers products and services including Diagnóstico Microbiológico Digital, Plataforma Neobiome, and Sequenciamento de Genomas. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery.

Company details

Neoprospecta was founded in 2010 in Florianópolis, Brazil, focusing on microbial analysis in the biotechnology sector. Services encompass next-generation sequencing on the Illumina platform, bespoke bioinformatics, and qPCR for applications including infectious disease surveillance, antibiotic resistance monitoring, and contamination tracking in food, hospitals, and animal health. Digital Microbiological Diagnosis tools, such as DMD Microbiome for fungi, bacteria, and protozoa identification, and DMD Resistoma for resistance gene detection, are provided.

Key Metrics
  • Total Equity Funding
    $1.78M (USD)

    in 1 rounds

  • Latest Funding Round
    $1.78M (USD), Seed

    Sep 2014

  • Investors

Products & Services of Neoprospecta

Neoprospecta offers a comprehensive portfolio of products and services, including Diagnóstico Microbiológico Digital, Plataforma Neobiome, and Sequenciamento de Genomas.

Diagnóstico Microbiológico Digital
Diagnostic Tool

Identifies microorganisms using genetic markers and DNA sequencing.

Plataforma Neobiome
Analysis Platform

Manages and analyzes microbial data for quality control applications.

Sequenciamento de Genomas
Sequencing Service

Performs genome and transcriptome sequencing for research and diagnostics.

Apps and channels of Neoprospecta

its YouTube channel Neoprospecta Microbiome Technologies has 1.06K subscribers and 30 videos.

Neoprospecta Microbiome Technologies
YouTube 1.06K subscribers 30 videos Science & Technology
Open channel

Videos from Neoprospecta

The most watched videos on Neoprospecta's YouTube channel, Neoprospecta Microbiome Technologies (1.06K subscribers). Click a video to play it here.

Sequenciamento de DNA para prevenção de riscos
41.7K views
Tome açõespreditivas para evitar perdas.
23.2K views
Neoprospecta e Universidades: Parcerias que impulsionam a ciência no Brasil
7.7K views
Neobox - Espia só o MinION em ação
5.9K views

More on Neoprospecta Microbiome Technologies.

Funding Insights of Neoprospecta

Neoprospecta has successfully raised a total of $1.78M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.78 million completed in September 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $1.78M
  • Total Rounds 1
  • Last Round Seed — $1.78M
  • First Round $1.78M

    (Sep 2014)

  • Investors Count 1

All 1 funding rounds of Neoprospecta with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2014$1.78MSeed–CVentures
–
Valuation history

1 investors in total: 1 institutional.

Investors in Neoprospecta

Neoprospecta has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include CVentures.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
cventureseg.com
Premium access

Investor details for Neoprospecta

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Neoprospecta

2 dated milestones of Neoprospecta across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Neoprospecta is founded.
  2. Funding First funding round of $1.8M.

Web traffic of Neoprospecta

The website of Neoprospecta (neoprospecta.com) receives about 7.9K visits a month.

  • Monthly visits
    7.9K

    ▼ 8.7% vs previous month

Similar websites

Websites whose visitors overlap most with Neoprospecta. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
biocant.pt
100%
1.9K#7,429,645View details
lifesci.dundee.ac.uk
lifesci.dundee.ac.uk
92%
–
masslifesciences.com
91%
#828,340View details
ifsudestemg.edu.br
ifsudestemg.edu.br
58%
#86,363–
science.uwe.ac.uk
science.uwe.ac.uk
57%
–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 6 similar websites and full traffic analytics for Neoprospecta

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 6 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Neoprospecta

Neoprospecta was founded in 2010 and raised its 1st funding round 4 years after it was founded.

Neoprospecta is headquartered in Florianopolis, Brazil. It is registered at Florianopolis, Santa Catarina, Brazil.

Neoprospecta is a funded company, having raised a total of $1.78M across 1 funding round to date. The company's 1st funding round was a Seed of $1.78M, raised on Sep 2014.

Neoprospecta was founded in 2010 in Florianópolis, Brazil, focusing on microbial analysis in the biotechnology sector. Services encompass next-generation sequencing on the Illumina platform, bespoke bioinformatics, and qPCR for applications including infectious disease surveillance, antibiotic resistance monitoring, and contamination tracking in food, hospitals, and animal health. Digital Microbiological Diagnosis tools, such as DMD Microbiome for fungi, bacteria, and protozoa identification, and DMD Resistoma for resistance gene detection, are provided.

Neoprospecta offers Diagnóstico Microbiológico Digital, Plataforma Neobiome, and Sequenciamento de Genomas.

Neoprospecta has 1 investor. Key investors include CVentures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available